Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP680402.RARBbkQsXiPIR4OaXxgd7kbDDBTRdA-w7KGVpyD7Z-K0A130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP680402.RARBbkQsXiPIR4OaXxgd7kbDDBTRdA-w7KGVpyD7Z-K0A130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP680402.RARBbkQsXiPIR4OaXxgd7kbDDBTRdA-w7KGVpyD7Z-K0A130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP680402.RARBbkQsXiPIR4OaXxgd7kbDDBTRdA-w7KGVpyD7Z-K0A130_provenance.
- NP680402.RARBbkQsXiPIR4OaXxgd7kbDDBTRdA-w7KGVpyD7Z-K0A130_assertion description "[Biglycan has been considered a good candidate for neuromuscular disease based on direct interactions with collagen VI and alpha-dystroglycan, both of which are linked with congenital muscular dystrophy (CMD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP680402.RARBbkQsXiPIR4OaXxgd7kbDDBTRdA-w7KGVpyD7Z-K0A130_provenance.
- NP680402.RARBbkQsXiPIR4OaXxgd7kbDDBTRdA-w7KGVpyD7Z-K0A130_assertion evidence source_evidence_literature NP680402.RARBbkQsXiPIR4OaXxgd7kbDDBTRdA-w7KGVpyD7Z-K0A130_provenance.
- NP680402.RARBbkQsXiPIR4OaXxgd7kbDDBTRdA-w7KGVpyD7Z-K0A130_assertion SIO_000772 18602826 NP680402.RARBbkQsXiPIR4OaXxgd7kbDDBTRdA-w7KGVpyD7Z-K0A130_provenance.
- NP680402.RARBbkQsXiPIR4OaXxgd7kbDDBTRdA-w7KGVpyD7Z-K0A130_assertion wasDerivedFrom befree-2016 NP680402.RARBbkQsXiPIR4OaXxgd7kbDDBTRdA-w7KGVpyD7Z-K0A130_provenance.
- NP680402.RARBbkQsXiPIR4OaXxgd7kbDDBTRdA-w7KGVpyD7Z-K0A130_assertion wasGeneratedBy ECO_0000203 NP680402.RARBbkQsXiPIR4OaXxgd7kbDDBTRdA-w7KGVpyD7Z-K0A130_provenance.
- befree-2016 importedOn "2016-02-19" NP680402.RARBbkQsXiPIR4OaXxgd7kbDDBTRdA-w7KGVpyD7Z-K0A130_provenance.